Glycosylation: impact, control and improvement during therapeutic protein production

References

• Abe H, Takaoka Y, Chiba Y, et al. (2009). Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins. Glycobiology, 19, 428–36
   PubMed Web of Science ®Google Scholar
• Abès R, Teillaud J-L. (2010). Impact of glycosylation on effector functions of therapeutic IgG. Pharmaceuticals, 3, 146–57
   Google Scholar
• Altmann F, Staudacher E, Wilson IBH, März L. (1999). Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconjugate J, 16, 109–23
   PubMed Web of Science ®Google Scholar
• Andersen D. 2004. Cell culture effects on the glycosylation of therapeutic proteins. Bioprocess International. IBC LifeSciences
   Google Scholar
• Andersen DC, Goochee CF. (1994). The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. Curr Opin Biotechnol, 5, 546–9
   PubMedGoogle Scholar
• Andersen DC, Reilly DE. (2004). Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol, 15, 456–62
   PubMed Web of Science ®Google Scholar
• Baker K, Flatman S, Birch J. (2007). Product characterization from gene to therapeutic product. Medicines from animal cell culture. Chichester, UK: John Wiley & Sons, Ltd., 433–42
   Google Scholar
• Baker KN, Rendall MH, Hills AE, et al. (2001). Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnol Bioeng, 73, 188–202
   PubMed Web of Science ®Google Scholar
• Bañó-Polo M, Baldin F, Tamborero S, et al. (2011). N-glycosylation efficiency is determined by the distance to the C-terminus and the amino acid preceding an Asn-Ser-Thr sequon. Protein Sci, 20, 179–86
   PubMed Web of Science ®Google Scholar
• Bardor M, Faveeuw C, Fitchette A-C, et al. (2003). Immunoreactivity in mammals of two typical plant glyco-epitopes, core α(1,3)-fucose and core xylose. Glycobiology, 13, 427–34
   PubMed Web of Science ®Google Scholar
• Beck A, Wagner-Rousset E, Bussat M, et al. (2008). Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. Curr Pharm Biotechnol, 9, 482–501
   PubMed Web of Science ®Google Scholar
• Bertozzi C, Rabuka D. (2009). Structural basis of glycan diversity. In: Varki A, Cummings R, Esko J, et al., eds. Essentials of glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 601--16
   Google Scholar
• Bigge J, Patel T, Bruce J, et al. (1995). Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem, 230, 229–38
   PubMed Web of Science ®Google Scholar
• Birch JR, Racher AJ. (2006). Antibody production. Adv Drug Delivery Rev, 58, 671–85
   PubMed Web of Science ®Google Scholar
• Bobrowicz P, Davidson RC, Li H, et al. (2004). Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose. Glycobiology, 14, 757–66
   PubMed Web of Science ®Google Scholar
• Bollati-Fogolín M, Forno G, Nimtz M, et al. (2005). Temperature reduction in cultures of hGM-CSF-expressing CHO cells: effect on productivity and product quality. Biotechnol Prog, 21, 17–21
   PubMed Web of Science ®Google Scholar
• Bork K, Horstkorte R, Weidemann W. (2009). Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway. J Pharm Sci, 98, 3499–508
   PubMed Web of Science ®Google Scholar
• Borys MC, Linzer DIH, Papoutsakis ET. (1993). Culture pH affects expression rates and glycosylation of recombinant mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells. Nat Biotech, 11, 720–4
   Google Scholar
• Borys MC, Linzer DIH, Papoutsakis ET. (1994). Ammonia affects the glycosylation patterns of recombinant mouse placental lactogen-I by chinese hamster ovary cells in a pH-dependent manner. Biotechnol Bioeng, 43, 505–14
   PubMed Web of Science ®Google Scholar
• Boyd P, Lines A, Patel A. (1995). The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. Mol Immunol, 32, 1311–18
   PubMed Web of Science ®Google Scholar
• Brooks S. (2004). Appropriate glycosylation of recombinant proteins for human use. Mol Biotechnol, 28, 241–55
   PubMed Web of Science ®Google Scholar
• Brooks S. (2009). Strategies for analysis of the glycosylation of proteins: current status and future perspectives. Mol Biotechnol, 43, 76–88
   PubMed Web of Science ®Google Scholar
• Brunner D, Frank J, Appl H, et al. (2010). Serum-free cell culture: the serum-free media interactive online database. ALTEX, 27, 53–62
   PubMedGoogle Scholar
• Bulleid N, Bassel-Duby R, Freedman R, et al. (1992). Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylation. Biochem J, 286, 275–80
   PubMed Web of Science ®Google Scholar
• Burgener A, Butler M. (2006). Medium development. In: Ozturk S, Hu W-S, eds. Cell culture technology for pharmaceutical and cell-based therapies. Boca Raton, FL: CRC Press, 41–80
   Google Scholar
• Butler M, ed. (2004). Animal cell culture and technology. Oxford, UK: BIOS Scientific Publishers, 256 p
   Google Scholar
• Butler M. (2005). Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals. Appl Microbiol Biotechnol, 68, 283–91
   PubMed Web of Science ®Google Scholar
• Butters TD. (2002). Control in the N-linked glycoprotein biosynthesis pathway. Chem Biol, 9, 1266–8
   PubMedGoogle Scholar
• Campbell MP, Royle L, Radcliffe CM, et al. (2008). GlycoBase and autoGU: tools for HPLC-based glycan analysis. Bioinformatics, 24, 1214–16
   PubMed Web of Science ®Google Scholar
• Castilho A, Gattinger P, Grass J, et al. (2011). N-Glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology, 21, 813–23
   PubMed Web of Science ®Google Scholar
• Castro P, Ison A, Hayter P, Bull A. (1995). The macroheterogeneity of recombinant human interferon-gamma produced by Chinese-hamster ovary cells is affected by the protein and lipid content of the culture medium. Biotechnol Appl Biochem, 21, 87–100
   PubMed Web of Science ®Google Scholar
• Cereghino JL, Cregg JM. (2000). Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev, 24, 45–66
   PubMed Web of Science ®Google Scholar
• Chenu S, Grégoire A, Malykh Y, et al. (2003). Reduction of CMP-N-acetylneuraminic acid hydroxylase activity in engineered Chinese hamster ovary cells using an antisense-RNA strategy. Biochim Biophys Acta, Gen Subj, 1622, 133–44
   PubMed Web of Science ®Google Scholar
• Chiba Y, Jigami Y. (2007). Production of humanized glycoproteins in bacteria and yeasts. Curr Opin Chem Biol, 11, 670–6
   PubMed Web of Science ®Google Scholar
• Chotigeat W, Watanapokasin Y, Mahler S, Gray PP. (1994). Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells. Cytotechnology, 15, 217–21
   PubMed Web of Science ®Google Scholar
• Chu L, Robinson DK. (2001). Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol, 12, 180–7
   PubMed Web of Science ®Google Scholar
• Chung CH, Mirakhur B, Chan E, et al. (2008). Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose. N Engl J Med, 358, 1109–17
   PubMed Web of Science ®Google Scholar
• Clark KJR, Chaplin FWR, Harcum SW. (2004). Temperature effects on product-quality-related enzymes in batch CHO cell cultures producing recombinant tPa. Biotechnol Prog, 20, 1888–92
   PubMed Web of Science ®Google Scholar
• Crispin M, Bowden TA, Coles CH, et al. (2009). Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions. J Mol Biol, 387, 1061–6
   Google Scholar
• Crowell CK, Grampp GE, Rogers GN, et al. (2007). Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system. Biotechnol Bioeng, 96, 538–49
   PubMed Web of Science ®Google Scholar
• Cruz HJ, Freitas CM, Alves PM, et al. (2000). Effects of ammonia and lactate on growth, metabolism, and productivity of BHK cells. Enzyme Microb Technol, 27, 43–52
   PubMed Web of Science ®Google Scholar
• Cummings RD, Etzler ME. (2009). Antibodies and lectins in glycan analysis. In: Varki A, Cummings R, Esko J, eds. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press
   Google Scholar
• Dalpathado DS, Desaire H. (2008). Glycopeptide analysis by mass spectrometry. Analyst, 133, 731–8
   PubMed Web of Science ®Google Scholar
• Dasgupta S, Navarrete A-M, Bayry J, et al. (2007). A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes. Proc Nat Acad Sci, 104, 8965–70
   PubMed Web of Science ®Google Scholar
• Davies J, Jiang LY, Pan L-Z, et al. (2001). Expression of GnTIII in recombinant anti-CD20 CHO production cell line: expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FcyRIII. Biotechnol Bioeng, 74, 288–94
   PubMed Web of Science ®Google Scholar
• De Pourcq K, De Schutter K, Callewaert N. (2010). Engineering of glycosylation in yeast and other fungi: current state and perspectives. Appl Microbiol Biotechnol, 87, 1617–31
   PubMed Web of Science ®Google Scholar
• Dempski Jr RE, Imperiali B. (2002). Oligosaccharyl transferase: gatekeeper to the secretory pathway. Curr Opin Chem Biol, 6, 844–50
   PubMed Web of Science ®Google Scholar
• Dingermann T. (2008). Recombinant therapeutic proteins: production platforms and challenges. Biotechnol J, 3, 90–7
   PubMedGoogle Scholar
• Domann PJ, Pardos-Pardos AC, Fernandes DL, et al. (2007). Separation-based glycoprofiling approaches using fluorescent labels. Proteomics, 7, 70–6
   PubMedGoogle Scholar
• Durocher Y, Butler M. (2009). Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol, 20, 700–7
   PubMed Web of Science ®Google Scholar
• Dwek MV, Rawlings SL. (2006). Breast cancer proteomics using two-dimensional electrophoresis: studying the breast cancer proteome. Meth Mol Med, 120, 231–43
   PubMedGoogle Scholar
• Egrie JC, Browne JK. (2001). Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer, 84, 3–10
   PubMed Web of Science ®Google Scholar
• Elliott S, Lorenzini T, Asher S, et al. (2003). Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotech, 21, 414–21
   PubMed Web of Science ®Google Scholar
• Erbayraktar S, Grasso G, Sfacteria A, et al. (2003). Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Nat Acad Sci, 100, 6741–6
   PubMed Web of Science ®Google Scholar
• Fenn J, Mann M, Meng C, et al. (1989). Electrospray ionization for mass spectrometry of large biomolecules. Science, 246, 64–71
   PubMed Web of Science ®Google Scholar
• Ferrara C, Brünker P, Suter T, et al. (2006a). Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II. Biotechnol Bioeng, 93, 851–61
   PubMed Web of Science ®Google Scholar
• Ferrara C, Stuart F, Sondermann P, et al. (2006b). The Carbohydrate at FcγRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J Biol Chem, 281, 5032–6
   PubMed Web of Science ®Google Scholar
• Fukuta K, Abe R, Yokomatsu T, et al. (2000a). Remodeling of sugar chain structures of human interferon-γ. Glycobiology, 10, 421–30
   PubMed Web of Science ®Google Scholar
• Fukuta K, Yokomatsu T, Abe R, et al. (2000b). Genetic engineering of CHO cells producing human interferon-γ by transfection of sialyltransferases. Glycoconjugate J, 17, 895–904
   PubMed Web of Science ®Google Scholar
• Galili U, Rachmilewitz E, Peleg A, Flechner I. (1984). A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med, 160, 1519–31
   PubMed Web of Science ®Google Scholar
• Garcia-Casado G, Sanchez-Monge R, Chrispeels MJ, et al. (1996). Role of complex asparagine-linked glycans in the allergenicity of plant glycoproteins. Glycobiology, 6, 471–7
   PubMed Web of Science ®Google Scholar
• Gawlitzek M, Ryll T, Lofgren J, Sliwkowski MB. (2000). Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. Biotechnol Bioeng, 68, 637–46
   PubMed Web of Science ®Google Scholar
• Gawlitzek M, Valley U, Nimtz M, et al. (1995). Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions. J Biotechnol, 42, 117–31
   PubMed Web of Science ®Google Scholar
• Geigert J. (2004). The challenge of CMC regulatory compliance for biopharmaceuticals. New York: Springer, 386 p
   Google Scholar
• Geng M, Zhang X, Bina M, Regnier F. (2001). Proteomics of glycoproteins based on affinity selection of glycopeptides from tryptic digests. J Chromatogr, B: Biomed Sci Appl, 752, 293–306
   PubMed Web of Science ®Google Scholar
• Gennaro LA, Salas-Solano O. (2008). On-line CE−LIF−MS technology for the direct characterization of N-linked glycans from therapeutic antibodies. Anal Chem, 80, 3838–45
   PubMed Web of Science ®Google Scholar
• Goh JSY, Zhang P, Fai Chan K, et al. (2010). RCA-I-resistant CHO mutant cells have dysfunctional GnT I and expression of normal GnT I in these mutants enhances sialylation of recombinant erythropoietin. Metab Eng, 12, 360–8
   Google Scholar
• Goldman MH, James DC, Rendall M, et al. (1998). Monitoring recombinant human interferon-gamma N-glycosylation during perfused fluidized-bed and stirred-tank batch culture of CHO cells. Biotechnol Bioeng, 60, 596–607
   PubMed Web of Science ®Google Scholar
• Gomord V, Faye Lc. (2004). Posttranslational modification of therapeutic proteins in plants. Curr Opin Plant Biol, 7, 171–81
   PubMed Web of Science ®Google Scholar
• Goochee CF, Gramer MJ, Andersen DC, et al. (1991). The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties. Nat Biotech, 9, 1347–55
   Google Scholar
• Gramer MJ, Goochee CF. (1993). Glycosidase activities in chinese hamster ovary cell lysate and cell culture supernatant. Biotechnol Prog, 9, 366–73
   PubMed Web of Science ®Google Scholar
• Gu X, Wang DIC. (1998). Improvement of interferon-γ sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine. Biotechnol Bioeng, 58, 642–8
   PubMed Web of Science ®Google Scholar
• Guile GR, Rudd PM, Wing DR, et al. (1996). A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem, 240, 210–26
   PubMed Web of Science ®Google Scholar
• Guile GR, Wong SYC, Dwek RA. (1994). Analytical and preparative separation of anionic oligosaccharides by weak anion-exchange high-performance liquid chromatography on an inert polymer column. Anal Biochem, 222, 231–5
   PubMed Web of Science ®Google Scholar
• Hahn TJ, Goochee CF. (1992). Growth-associated glycosylation of transferrin secreted by HepG2 cells. J Biol Chem, 267, 23982–7
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Gerngross TU. (2007). Glycosylation engineering in yeast: the advent of fully humanized yeast. Curr Opin Biotechnol, 18, 387–92
   PubMed Web of Science ®Google Scholar
• Harcum SW. (2006). Protein glycosylation. In: Ozturk S, Hu W-S, eds. Cell Culture Technology for Pharmaceutical and Cell-based Therapies. Boca Raton (FL): CRC Press
   Google Scholar
• Hayter PM, Curling EM, Baines AJ, et al. (1992). Glucose-limited chemostat culture of chinese hamster ovary cells producing recombinant human interferon-gamma. Biotechnol Bioeng, 39, 327–35
   PubMed Web of Science ®Google Scholar
• Hayter PM, Curling EMA, Gould ML, et al. (1993). The effect of the dilution rate on CHO cell physiology and recombinant interferon-γ production in glucose-limited chemostat culture. Biotechnol Bioeng, 42, 1077–85
   PubMed Web of Science ®Google Scholar
• Helenius A, Aebi M. (2001). Intracellular functions of N-glycans. Science, 291, 2364–9
   PubMed Web of Science ®Google Scholar
• Helenius J, Aebi M. (2002). Transmembrane movement of dolichol linked carbohydrates during N-glycoprotein biosynthesis in the endoplasmic reticulum. Semin Cell Dev Biol, 13, 171–8
   PubMed Web of Science ®Google Scholar
• Hellwig S, Drossard J, Twyman RM, Fischer R. (2004). Plant cell cultures for the production of recombinant proteins. Nat Biotech, 22, 1415–22
   PubMed Web of Science ®Google Scholar
• Hemström P, Irgum K. (2006). Hydrophilic interaction chromatography. J Sep Sci, 29, 1784–821
   PubMed Web of Science ®Google Scholar
• Hirano K, Macmillan D, Tezuka K, et al. (2009). Design and synthesis of a homogeneous erythropoietin analogue with two human complex-type sialyloligosaccharides: combined use of chemical and bacterial protein expression methods. Angew Chem, Int Ed, 48, 9557–60
   PubMed Web of Science ®Google Scholar
• Hodoniczky J, Zheng YZ, James DC. (2005). Control of recombinant monoclonal antibody effector functions by fc n-glycan remodeling in vitro. Biotechnol Prog, 21, 1644–52
   PubMed Web of Science ®Google Scholar
• Hossler P, Khattak SF, Li ZJ. (2009). Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology, 19, 936–49
   PubMed Web of Science ®Google Scholar
• Hsu K-L, Mahal LK. (2006). A lectin microarray approach for the rapid analysis of bacterial glycans. Nat Protoc, 1, 543–9
   PubMed Web of Science ®Google Scholar
• Huang Y-M, Hu W, Rustandi E, et al. (2010). Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog, 26, 1400–10
   PubMed Web of Science ®Google Scholar
• Huang Y, Mechref Y, Novotny MV. (2001). Microscale nonreductive release of o-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. Anal Chem, 73, 6063–9
   PubMed Web of Science ®Google Scholar
• Huhn C, Selman MHJ, Ruhaak LR, et al. (2009). IgG glycosylation analysis. Proteomics, 9, 882–913
   PubMed Web of Science ®Google Scholar
• Iida S, Misaka H, Inoue M, et al. (2006). Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcγRIIIa. Clin Cancer Rese, 12, 2879–87
   PubMed Web of Science ®Google Scholar
• James DC, Baker KN. (2002). Glycosylation of recombinant proteins. Encyclopedia of bioprocess technology. John Wiley & Sons, Inc
   Google Scholar
• Jayapal K, Wlaschin K, Hu W-S, Yap M. (2007). Recombinant protein therapeutics from CHO cells – 20 years and counting. CHO Consortium: SBE Special Edition, 40–7
   Google Scholar
• Jefferis R. (2005). Glycosylation of recombinant antibody therapeutics. Biotechnol Prog, 21, 11–16
   PubMed Web of Science ®Google Scholar
• Jefferis R. (2009a). Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discovery, 8, 226–34
   PubMed Web of Science ®Google Scholar
• Jefferis R. (2009b). Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. Trends Pharmacol Sci, 30, 356–62
   PubMed Web of Science ®Google Scholar
• Jenkins N, Castro P, Menon S, et al. (1994). Effect of lipid supplements on the production and glycosylation of recombinant interferon-gamma expressed in CHO cells. Cytotechnology, 15, 209–15
   PubMed Web of Science ®Google Scholar
• Jenkins N, Curling E. (1994). Glycosylation of recombinant proteins: problems and prospects. Enzyme Microb Technol, 16, 354–64
   PubMed Web of Science ®Google Scholar
• Jenkins N, Parekh RB, James DC. (1996). Getting the glycosylation right: Implications for the biotechnology industry. Nat Biotechnol, 14, 975–81
   PubMed Web of Science ®Google Scholar
• Jeong Y, Choi O, Lim H, et al. (2008). Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression. J Microbiol Biotechnol, 18, 1945
   PubMed Web of Science ®Google Scholar
• Jin C, Altmann F, Strasser R, et al. (2008). A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology, 18, 235–41
   PubMed Web of Science ®Google Scholar
• Jones AJS, Papac DI, Chin EH, et al. (2007). Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys. Glycobiology, 17, 529–40
   PubMed Web of Science ®Google Scholar
• Kamoda S, Kakehi K. (2006). Capillary electrophoresis for the analysis of glycoprotein pharmaceuticals. Electrophoresis, 27, 2495–504
   PubMed Web of Science ®Google Scholar
• Kanda Y, Yamada T, Mori K, et al. (2007). Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Glycobiology, 17, 104–18
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Nimmerjahn F, Ravetch JV. (2006). Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science, 313, 670–3
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Sato R, Aoyagi H. (2010). Changes in the quality of antibodies produced by Chinese hamster ovary cells during the death phase of cell culture. J Biosci Bioeng, 109, 281–7
   PubMed Web of Science ®Google Scholar
• Kang P, Mechref Y, Novotny MV. (2008). High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun Mass Spectrom, 22, 721–34
   PubMed Web of Science ®Google Scholar
• Kim YK, Shin HS, Tomiya N, et al. (2005). Production and N-glycan analysis of secreted human erythropoietin glycoprotein in stably transfected Drosophila S2 cells. Biotechnol Bioeng, 92, 452–61
   PubMed Web of Science ®Google Scholar
• Kimura R, Miller WM. (1997). Glycosylation of CHO-derived recombinant tPA produced under elevated pCO2. Biotechnol Prog, 13, 311–17
   PubMed Web of Science ®Google Scholar
• Kirkpatrick RB, Ganguly S, Angelichio M, et al. (1995). Heavy chain dimers as well as complete antibodies are efficiently formed and secreted from drosophila via a BiP-mediated pathway. J Biol Chem, 270, 19800–5
   PubMed Web of Science ®Google Scholar
• Kompella A, Lee V. (1991). Pharmacokinetics of peptide and protein drugs. In: Lee V, ed. Peptide and Protein Drug Delivery. New York: Marcel Dekker, 391–484
   Google Scholar
• Kornfeld R, Kornfeld S. (1985). Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem, 54, 631–64
   PubMed Web of Science ®Google Scholar
• Kost TA, Condreay JP, Jarvis DL. (2005). Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol, 23, 567–75
   PubMed Web of Science ®Google Scholar
• Kumpel B, Rademacher T, Rook G, et al. (1994). Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. Hum Antibodies Hybridomas, 5, 143–51
   PubMedGoogle Scholar
• Kunkel JP, Jan DC, Butler M, Jamieson JC. (2000). Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors. Biotechnol Prog, 16, 462–70
   PubMed Web of Science ®Google Scholar
• Kunkel JP, Jan DC, Jamieson JC, Butler M. (1998). Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. J Biotechnol, 62, 55–71
   PubMed Web of Science ®Google Scholar
• Küster B, Krogh T, Mørtz E, Harvey D. (2001). Glycosylation analysis of gel-separated proteins. Proteomics, 1, 350–61
   PubMed Web of Science ®Google Scholar
• Lam JS, Huang H, Levitz SM. (2007). Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells. PLoS One, 2, e1009
   PubMedGoogle Scholar
• Lamotte D, Buckberry L, Monaco L, et al. (1999). Na-butyrate increases the production and α2,6-sialylation of recombinant interferon-γ expressed by α2,6-sialyltransferase engineered CHO cells. Cytotechnology, 29, 55–64
   PubMed Web of Science ®Google Scholar
• Larsen MR, Højrup P, Roepstorff P. (2005). Characterization of gel-separated glycoproteins using two-step proteolytic digestion combined with sequential microcolumns and mass spectrometry. Mol Cell Proteom, 4, 107–19
   PubMed Web of Science ®Google Scholar
• LeFloch F, Tessier B, Chenuet S, et al. (2006). Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells. Cytotechnology, 52, 39–53
   PubMed Web of Science ®Google Scholar
• Li H, d’Anjou M. (2009). Pharmacological significance of glycosylation in therapeutic proteins. Curr Opin Biotechnol, 20, 678–84
   PubMed Web of Science ®Google Scholar
• Li H, Sethuraman N, Stadheim TA, Zha D, et al. (2006). Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat Biotech, 24, 210–15
   PubMed Web of Science ®Google Scholar
• Liang M, Guttieri M, Lundkvist Å, Schmaljohn C. (1997). Baculovirus expression of a human g2-specific, neutralizing igg monoclonal antibody to puumala virus. Virology, 235, 252–60
   Google Scholar
• Lifely MR, Hale C, Boyce S, et al. (1995). Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. Glycobiology, 5, 813–22
   PubMed Web of Science ®Google Scholar
• Lim Y, Wong NSC, Lee YY, et al. (2010). Engineering mammalian cells in bioprocessing – current achievements and future perspectives. Biotechnol Appl Biochem, 55, 175–89
   PubMed Web of Science ®Google Scholar
• Lin Z, Lo A, Simeone DM, et al. (2012). An N-glycosylation analysis of human alpha-2-macroglobulin using an integrated approach. J Proteom Bioinf, 5, 124–34
   Google Scholar
• Lipscomb ML, Palomares LA, Hernández V, et al. (2005). Effect of production method and gene amplification on the glycosylation pattern of a secreted reporter protein in CHO cells. Biotechnol Prog, 21, 40–9
   PubMed Web of Science ®Google Scholar
• Lis H, Sharon N. (1993). Protein glycosylation. Eur J Biochem, 218, 1–27
   PubMedGoogle Scholar
• Liu C-H, Chang T-Y. (2006). Rational development of serum-free medium for Chinese hamster ovary cells. Proc Biochem, 41, 2314–19
   Web of Science ®Google Scholar
• Lowe JB, Marth JD. (2003). A genetic approach to mammalian glycan function. Annu Rev Biochem, 72, 643–91
   PubMed Web of Science ®Google Scholar
• Lund J, Takahashi N, Nakagawa H, et al. (1993). Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. Mol Immunol, 30, 741–8
   PubMedGoogle Scholar
• Luong M, Lam JS, Chen J, Levitz SM. (2007). Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. Vaccine, 25, 4340–4
   PubMed Web of Science ®Google Scholar
• Manzi A, Varki A. (1993). Compositional analysis of glycoproteins. In: Fukuda M, Kobata A, eds. Glycobiology: A Practical Approach. Oxford, UK: IRI Press, 27–77
   Google Scholar
• Marchal I, Jarvis DL, Cacan R, Verbert A. (2001). Glycoproteins from insect cells: sialylated or not? Biol Chem, 382, 151–9
   PubMed Web of Science ®Google Scholar
• Marino K, Bones J, Kattla JJ, Rudd PM. (2010). A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol, 6, 713–23
   PubMed Web of Science ®Google Scholar
• Marth J. (1999). N-Glycans. In: Varki A, Cummings R, Esko J, et al, eds. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press
   Google Scholar
• Masuda K, Kubota T, Kaneko E, et al. (2007). Enhanced binding affinity for FcγRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. Mol Immunol, 44, 3122–31
   PubMed Web of Science ®Google Scholar
• Matsumiya S, Yamaguchi Y, Saito J-I, et al. (2007). Structural comparison of fucosylated and nonfucosylated fc fragments of human immunoglobulin G1. J Mol Biol, 368, 767–79
   PubMed Web of Science ®Google Scholar
• Merry AH, Neville DCA, Royle L, et al. (2002). Recovery of intact 2-aminobenzamide-labeled o-glycans released from glycoproteins by hydrazinolysis. Anal Biochem, 304, 91–9
   PubMed Web of Science ®Google Scholar
• Merry TH, Royle L, Radcliffe CM, et al. (2004). Analysis of N- and O-linked glycans of glycoproteins. Encyclopedia of genetics, genomics, proteomics and bioinformatics. Chichester, UK: John Wiley & Sons, Ltd
   Google Scholar
• Mimura Y, Jefferis R, Mimura-Kimura Y, et al. (2009). Glycosylation of therapeutic IgGs. Therapeutic monoclonal antibodies. Hoboken, NJ: John Wiley & Sons, Inc., 67–89
   Google Scholar
• Mimura Y, Lund J, Church S, et al. (2001). Butyrate increases production of human chimeric IgG in CHO-K1 cells whilst maintaining function and glycoform profile. J Immunol Meth, 247, 205–16
   PubMed Web of Science ®Google Scholar
• Morell AG, Gregoriadis G, Scheinberg IH, et al. (1971). The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem, 246, 1461–7
   PubMed Web of Science ®Google Scholar
• Mori K, Kuni-Kamochi R, Yamane-Ohnuki N, et al. (2004). Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. Biotechnol Bioeng, 88, 901–8
   PubMed Web of Science ®Google Scholar
• Müthing J, Kemminer SE, Conradt HS, et al. (2003). Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. Biotechnol Bioeng, 83, 321–34
   PubMed Web of Science ®Google Scholar
• Nabi IR, Dennis JW. (1998). The extent of polylactosamine glycosylation of MDCK LAMP-2 is determined by its Golgi residence time. Glycobiology, 8, 947–53
   PubMed Web of Science ®Google Scholar
• Nahrgang S, Kragten E, De Jesus M, et al. (1999). The effect of cell line, transfection procedure and reactor conditions on the glycosylation of recombinant human anti-rhesus D IGG1. In: Bernard A, ed. Animal Cell Technology: Products from Cells, Cells as Products. Proceedings of the ESACT Meeting, 16th, Lugano; Apr 25–29; Switzerland, 259–61
   Google Scholar
• Narhi LO, Arakawa T, Aoki KH, et al. (1991). The effect of carbohydrate on the structure and stability of erythropoietin. J Biol Chem, 266, 23022–6
   PubMed Web of Science ®Google Scholar
• Natsume A, Niwa R, Satoh M. (2009). Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC. Drug Des Dev Ther, 3, 7–16
   PubMed Web of Science ®Google Scholar
• Niklas J, Schräder E, Sandig V, Noll T, Heinzle E. (2011). Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysis. Bioproc Biosys Eng, 34, 533–45
   PubMed Web of Science ®Google Scholar
• Nyberg GB, Balcarcel RR, Follstad BD, et al. (1999). Metabolic effects on recombinant interferon-gamma glycosylation in continuous culture of Chinese hamster ovary cells. Biotechnol Bioeng, 62, 336–47
   PubMed Web of Science ®Google Scholar
• Omasa T, Tanaka R, Doi T, et al. (2008). Decrease in antithrombin III fucosylation by expressing GDP-fucose transporter siRNA in Chinese hamster ovary cells. J Biosci Bioeng, 106, 168–73
   PubMed Web of Science ®Google Scholar
• Osborne C, Brooks SA. (2006). SDS-PAGE and Western blotting to detect proteins and glycoproteins of interest in breast cancer research. Method Mol Med, 120, 217–29
   PubMedGoogle Scholar
• Ozturk SS, Hu W-S. (2006). Cell culture technology for pharmaceutical and cell-based therapies. New York: CRC Press
   Google Scholar
• Padler-Karavani V, Yu H, Cao H, et al. (2008). Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology, 18, 818–30
   PubMed Web of Science ®Google Scholar
• Patel T, Parekh R, Moellering B, Prior C. (1992). Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody. Biochemical J, 285, 839–45
   PubMed Web of Science ®Google Scholar
• Patwa T, Li C, Simeone DM, Lubman DM. (2010). Glycoprotein analysis using protein microarrays and mass spectrometry. Mass Spectrom Rev, 29, 830–44
   PubMed Web of Science ®Google Scholar
• Perlman S, van den Hazel B, Christiansen J, et al. (2003). Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. J Clin Endocrin Metabol, 88, 3227–35
   PubMed Web of Science ®Google Scholar
• Peterman S, Mulholland J. (2006). A novel approach for identification and characterization of glycoproteins using a hybrid linear ion trap/FT-ICR mass spectrometer. J Am Soc Mass Spectrom, 17, 168–79
   PubMed Web of Science ®Google Scholar
• Pilobello KT, Slawek DE, Mahal LK. (2007). A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome. Proc Nat Acad Sci, 104, 11534–9
   PubMed Web of Science ®Google Scholar
• Preithner S, Elm S, Lippold S, et al. (2006). High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G. Mol Immunol, 43, 1183–93
   PubMed Web of Science ®Google Scholar
• Raju TS. (2003). Glycosylation variations with expression systems and their impact on biological activity of therapeutic immunoglobulins. BioProc Int, 1, 44–53
   Google Scholar
• Raju TS. (2008). Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol, 20, 471–8
   PubMed Web of Science ®Google Scholar
• Raju TS, Scallon B. (2007). Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain. Biotechnol Prog, 23, 964–71
   PubMed Web of Science ®Google Scholar
• Rearick JI, Chapman A, Kornfeld S. (1981). Glucose starvation alters lipid-linked oligosaccharide biosynthesis in Chinese hamster ovary cells. J Biol Chem, 256, 6255–61
   PubMed Web of Science ®Google Scholar
• Restelli V, Butler M. (2002). The effect of cell culture parameters on protein glycosylation. In: Al-Rubeai M, ed. Glycosylation. Dordrecht: Kluwer Publishers, 61–92
   Google Scholar
• Reuter G, Gabius H. (1999). Eukaryotic glycosylation: whim of nature or multipurpose tool? Cell and Mol Life Sci, 55, 368–422
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Spearman M, Huzel N, Butler M. (2005). Enhanced production of monomeric interferon-beta by CHO cells through the control of culture conditions. Biotechnol Prog, 21, 22–30
   PubMed Web of Science ®Google Scholar
• Roth Z, Yehezkel G, Khalaila I. (2012). Identification and quantification of protein glycosylation. Int J Carbohydr Chem, 2012, 1–10
   Google Scholar
• Rothman RJ, Warren L, Vliegenthart JFG, Hard KJ. (1989). Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas. Biochemistry, 28, 1377–84
   PubMed Web of Science ®Google Scholar
• Royle L, Dwek RA, Rudd PM. (2001). Determining the structure of oligosaccharides N- and O-linked to glycoproteins. Current protocols in protein science. Hoboken, NJ: John Wiley & Sons, Inc
   Google Scholar
• Royle L, Mattu TS, Hart E, et al. (2002). An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. Anal Biochem, 304, 70–90
   PubMed Web of Science ®Google Scholar
• Royle L, Radcliffe CM, Dwek RA, Rudd PM. (2007). Detailed structural analysis of n-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. In: Brockhausen I, ed. Glycobiology protocols. Totowa, NJ: Humana Press, 125–43
   Google Scholar
• Runkel L, Meier W, Pepinsky RB, et al. (1998). Structural and Functional differences between glycosylated and non-glycosylated forms of human interferon-β (IFN-β). Pharm Res, 15, 641–9
   PubMed Web of Science ®Google Scholar
• Ryll T, Dutina G, Reyes A, et al. (2000). Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention: characterization of separation efficiency and impact of perfusion on product quality. Biotechnol Bioeng, 69, 440–9
   PubMedGoogle Scholar
• Sareneva T, Cantell K, Pyhälä L, et al. (1993). Effect of carbohydrates on the pharmacokinetics of human interferon-gamma. J Interferon Res, 13, 267–9
   PubMedGoogle Scholar
• Sareneva T, Mørtz E, Tölö H, et al. (1996). Biosynthesis and N-glycosylation of human interferon-γ. Eur J Biochem, 242, 191–200
   PubMedGoogle Scholar
• Sasaki H, Bothner B, Dell A, Fukuda M. (1987). Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem, 262, 12059–76
   PubMed Web of Science ®Google Scholar
• Satoh M, Iida S, Shitara K. (2006). Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opin Biol Ther, 6, 1161–73
   PubMed Web of Science ®Google Scholar
• Scallon BJ, Tam SH, McCarthy SG, et al. (2007). Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol, 44, 1524–34
   PubMed Web of Science ®Google Scholar
• Schräder E, Scholz S, Niklas J, et al. (2011). Characterisation of cultivation of the human cell line AGE1.HN.AAT. BMC Proceedings, 5, 1–2
   Google Scholar
• Schumann W, Ferreira LCS. (2004). Production of recombinant proteins in Escherichia coli. Gen Mol Biol, 27, 442–53
   Web of Science ®Google Scholar
• Schuster M, Umana P, Ferrara C, et al. (2005). Improved effector functions of a therapeutic monoclonal lewis y-specific antibody by glycoform engineering. Cancer Res, 65, 7934–41
   Google Scholar
• Sethuraman N, Stadheim TA. (2006). Challenges in therapeutic glycoprotein production. Curr Opin Biotechnol, 17, 341–6
   PubMed Web of Science ®Google Scholar
• Sheeley DM, Merrill BM, Taylor LCE. (1997). Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal α-linked galactose. Anal Biochem, 247, 102–10
   PubMed Web of Science ®Google Scholar
• Shelikoff M, Sinskey AJ, Stephanopoulos G. (1994). The effect of protein synthesis inhibitors on the glycosylation site occupancy of recombinant human prolactin. Cytotechnology, 15, 195–208
   PubMed Web of Science ®Google Scholar
• Shields RL, Lai J, Keck R, et al. (2002). Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity. J Biol Chem, 277, 26733–40
   PubMed Web of Science ®Google Scholar
• Shinkawa T, Nakamura K, Yamane N, et al. (2003). The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem, 278, 3466–73
   PubMed Web of Science ®Google Scholar
• Sinclair AM, Elliott S. (2005). Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci, 94, 1626–35
   PubMed Web of Science ®Google Scholar
• Smalling R, Foote M, Molineux G, et al. (2004). Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge. Biotechnol Ann Rev, 10, 237–50
   PubMedGoogle Scholar
• Soderquist RG, Lee JM. (2005). Enhanced production of recombinant proteins from plant cells by the application of osmotic stress and protein stabilization. Plant Cell Rep, 24, 127–32
   PubMed Web of Science ®Google Scholar
• Solá RJ, Griebenow K. (2009). Effects of glycosylation on the stability of protein pharmaceuticals. J Pharm Sci, 98, 1223–45
   PubMed Web of Science ®Google Scholar
• Sondermann P, Kaiser J, Jacob U. (2001). Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. J Mol Biol, 309, 737–49
   PubMed Web of Science ®Google Scholar
• Spearman M, Rodriguez J, Huzel N, Butler M. (2005). Production and glycosylation of recombinant β-interferon in suspension and cytopore microcarrier cultures of CHO cells. Biotechnol Prog, 21, 31–9
   PubMed Web of Science ®Google Scholar
• Stark N, Heath E. (1979). Glucose-dependent glycosylation of secretory glycoprotein in mouse myeloma cells. Arch Biochem Biophys, 192, 599–609
   PubMed Web of Science ®Google Scholar
• Strasser R, Stadlmann J, Schähs M, et al. (2008). Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J, 6, 392–402
   PubMed Web of Science ®Google Scholar
• Sung YH, Song YJ, Lim SW, et al. (2004). Effect of sodium butyrate on the production, heterogeneity and biological activity of human thrombopoietin by recombinant Chinese hamster ovary cells. J Biotechnol, 112, 323–35
   PubMed Web of Science ®Google Scholar
• Swiech K, Picanço-Castro V, Covas DT. (2012). Human cells: new platform for recombinant therapeutic protein production. Protein Expr Purif, 84, 147–53
   PubMed Web of Science ®Google Scholar
• Tarelli E. (2007). Glycosylation of medicinal products. Medicines from animal cell culture. Chichester, UK: John Wiley & Sons, Ltd., 479–90
   Google Scholar
• Taverna M, Tran NT, Merry T, et al. (1998). Electrophoretic methods for process monitoring and the quality assessment of recombinant glycoproteins. Electrophoresis, 19, 2572–94
   PubMed Web of Science ®Google Scholar
• Taylor ME, Drickamer K. (2006). Introduction to glycobiology. Oxford, USA: Oxford University Press
   Google Scholar
• Townsend R, Stahl P. (1981). Isolation and characterization of a mannose/N-acetylglucosamine/fucose-binding protein from rat liver. Biochem J, 194, 209–14
   PubMed Web of Science ®Google Scholar
• Townsend RR, Hardy MR. (1991). Analysis of glycoprotein oligosaccharides using high-pH anion exchange chromatography. Glycobiology, 1, 139–47
   PubMedGoogle Scholar
• Tran NT, Taverna M, Merry AH, et al. (2000). A sensitive mapping strategy for monitoring the reproducibility of glycan processing in an HIV vaccine, RGP-160, expressed in a mammalian cell line. Glycoconjugate J, 17, 401–6
   PubMed Web of Science ®Google Scholar
• Tretter V, Altmann F, März L. (1991). Peptide-N4-(N-acetyl-β-glucosaminyl)asparagine amidase F cannot release glycans with fucose attached α1 → 3 to the asparagine-linked N-acetylglucosamine residue. Eur J Biochem, 199, 647–52
   PubMedGoogle Scholar
• Trummer E, Fauland K, Seidinger S, et al. (2006a). Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors. Biotechnol Bioeng, 94, 1033–44
   PubMed Web of Science ®Google Scholar
• Trummer E, Fauland K, Seidinger S, et al. (2006b). Process parameter shifting: Part II. Biphasic cultivation – a tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells. Biotechnol Bioeng, 94, 1045–52
   PubMed Web of Science ®Google Scholar
• Umana P, Jean-Mairet J, Moudry R, et al. (1999). Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotech, 17, 176–80
   PubMed Web of Science ®Google Scholar
• Valley U, Nimtz M, Conradt HS, Wagner R. (1999). Incorporation of ammonium into intracellular UDP-activated N-acetylhexosamines and into carbohydrate structures in glycoproteins. Biotechnol Bioeng, 64, 401–17
   PubMed Web of Science ®Google Scholar
• Van den Steen P, Rudd PM, Dwek RA, Opdenakker G. (1998). Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol, 33, 151–208
   PubMed Web of Science ®Google Scholar
• van Kasteren SI, Kramer HB, Jensen HH, et al. (2007). Expanding the diversity of chemical protein modification allows post-translational mimicry. Nature, 446, 1105–9
   PubMed Web of Science ®Google Scholar
• Voisard D, Meuwly F, Ruffieux PA, et al. (2003). Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells. Biotechnol Bioeng, 82, 751–65
   PubMed Web of Science ®Google Scholar
• Vugmeyster Y, Howell K. (2004). Rituximab-mediated depletion of cynomolgus monkey B cells in vitro in different matrices: possible inhibitory effect of IgG. Int Immunopharm, 4, 1117–24
   PubMed Web of Science ®Google Scholar
• Wada Y, Gu J, Okamoto N, Inui K. (1994). Diagnosis of carbohydrate-deficient glycoprotein syndrome by matrix-assisted laser desorption time-of-flight mass spectrometry. Biol Mass Spectrom, 23, 108–9
   PubMedGoogle Scholar
• Waegeman H, Mey MD. (2012). Increasing recombinant protein production in E. coli by an alternative method to reduce acetate. In: Petre M, ed. Advances in Applied Biotechnology. In-Tech, 127–44
   Google Scholar
• Walsh G. (2010). Biopharmaceutical benchmarks 2010. Nat Biotech, 28, 917–24
   PubMed Web of Science ®Google Scholar
• Walsh G, Jefferis R. (2006). Post-translational modifications in the context of therapeutic proteins. Nat Biotech, 24, 1241–52
   PubMed Web of Science ®Google Scholar
• Wang L-X. (2008). Chemoenzymatic synthesis of glycopeptides and glycoproteins through endoglycosidase-catalyzed transglycosylation. Carbohydr Res, 343, 1509–22
   PubMed Web of Science ®Google Scholar
• Wang L-X, Lomino JV. (2011). Emerging technologies for making glycan-defined glycoproteins. ACS Chem Biol, 7, 110–22
   PubMed Web of Science ®Google Scholar
• Wang WC, Lee N, Aoki D, et al. (1991). The poly-N-acetyllactosamines attached to lysosomal membrane glycoproteins are increased by the prolonged association with the Golgi complex. J Biol Chem, 266, 23185–90
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu S-l, Hancock WS. (2006). Monitoring of glycoprotein products in cell culture lysates using lectin affinity chromatography and capillary HPLC coupled to electrospray linear ion trap-Fourier transform mass spectrometry (LTQ/FTMS). Biotechnol Prog, 22, 873–80
   PubMed Web of Science ®Google Scholar
• Watson E, Shah B, Leiderman L, et al. (1994). Comparison of N-linked oligosaccharides of recombinant human tissue kallikrein produced by Chinese hamster ovary cells on microcarrier beads and in serum-free suspension culture. Biotechnol Prog, 10, 39–44
   PubMed Web of Science ®Google Scholar
• Wei Y, Li C, Huang W, et al. (2008). Glycoengineering of human IgG1-Fc through combined yeast expression and in vitro chemoenzymatic glycosylation. Biochemistry, 47, 10294–304
   PubMed Web of Science ®Google Scholar
• Weigel PH, Yik JHN. (2002). Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim Biophys Acta, Gen Subj, 1572, 341–63
   PubMed Web of Science ®Google Scholar
• Weikert S, Papac D, Briggs J, et al. (1999). Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat Biotech, 17, 1116–21
   PubMed Web of Science ®Google Scholar
• Wileman T, Harding C, Stahl P. (1985). Receptor-mediated endocytosis. Biochem J, 232, 1–14
   PubMed Web of Science ®Google Scholar
• Wilson NL, Schulz BL, Karlsson NG, Packer NH. (2002). Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res, 1, 521–9
   PubMed Web of Science ®Google Scholar
• Wong CFD, Wong TKK, Goh TL, et al. (2005). Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. Biotechnol Bioeng, 89, 164–77
   PubMed Web of Science ®Google Scholar
• Wopereis S, Lefeber DJ, Morava É, Wevers RA. (2006). Mechanisms in protein o-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. Clin Chem, 52, 574–600
   PubMed Web of Science ®Google Scholar
• Wuhrer M, Catalina MI, Deelder AM, Hokke CH. (2007). Glycoproteomics based on tandem mass spectrometry of glycopeptides. J Chromatogr B, 849, 115–28
   PubMed Web of Science ®Google Scholar
• Wuhrer M, Koeleman CAM, Hokke CH, Deelder AM. (2004). Protein glycosylation analyzed by normal-phase nano-liquid chromatography–mass spectrometry of glycopeptides. Anal Chem, 77, 886–94
   Web of Science ®Google Scholar
• Wurm FM. (2004). Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol, 22, 1393–8
   PubMed Web of Science ®Google Scholar
• Yamane-Ohnuki N, Kinoshita S, Miho I-U, et al. (2004). Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol Bioeng, 87, 614–22
   PubMed Web of Science ®Google Scholar
• Yamane-Ohnuki N, Satoh M. (2009). Production of therapeutic antibodies with controlled fucosylation. MAbs, 1, 230–6
   PubMed Web of Science ®Google Scholar
• Yang J-D, Angelillo Y, Chaudhry M, et al. (2000). Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process. Biotechnol Bioeng, 69, 74–82
   PubMed Web of Science ®Google Scholar
• Yang M, Butler M. (2000a). Effect of ammonia on the glycosylation of human recombinant erythropoietin in culture. Biotechnol Prog, 16, 751–9
   PubMed Web of Science ®Google Scholar
• Yang M, Butler M. (2000b). Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. Biotechnol Bioeng, 68, 370–80
   PubMed Web of Science ®Google Scholar
• Yang M, Butler M. (2002). Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms. Biotechnol Prog, 18, 129–38
   PubMed Web of Science ®Google Scholar
• Yoon SK, Choi SL, Song JY, Lee GM. (2005). Effect of culture pH on erythropoietin production by Chinese hamster ovary cells grown in suspension at 32.5 and 37.0 °C. Biotechnol Bioeng, 89, 345–56
   PubMed Web of Science ®Google Scholar
• Yoon SK, Song JY, Lee GM. (2003). Effect of low culture temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cells. Biotechnol Bioeng, 82, 289–98
   PubMed Web of Science ®Google Scholar
• Yuen C, Storring P, Tiplady R, et al. (2003). Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures. Brit J Haematol, 121, 511–26
   PubMed Web of Science ®Google Scholar
• Zanghi JA, Schmelzer AE, Mendoza TP, et al. (1999). Bicarbonate concentration and osmolality are key determinants in the inhibition of CHO cell polysialylation under elevated pCO2 or pH. Biotechnol Bioeng, 65, 182–91
   PubMed Web of Science ®Google Scholar
• Zhang F, Murhammer D, Linhardt R. (2002). Enzyme kinetics and glycan structural characterization of secreted alkaline phosphatase prepared using the baculovirus expression vector system. Appl Biochem Biotechnol, 101, 197–210
   PubMed Web of Science ®Google Scholar
• Zhang J. (2010). Mammalian cell culture for biopharmaceutical production. In: Baltz RH, ed. Manual of Industrial Microbiology and Biotechnology. 3rd ed. Washington, DC: American Society of Microbiology. 157–78
   Google Scholar
• Zhao F-Q, Keating AF. (2007). Functional properties and genomics of glucose transporters. Curr Genomics, 8, 113–28
   PubMed Web of Science ®Google Scholar
• Zhou Q, Shankara S, Roy A, et al. (2008). Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function. Biotechnol Bioeng, 99, 652–65
   PubMed Web of Science ®Google Scholar
• Zhu J. (2011). Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv, 30, 1158–70
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li X, Mcvie-Wylie A, et al. (2005). Carbohydrate-remodelled acid α-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice. Biochem J, 389, 619–28
   PubMed Web of Science ®Google Scholar
• Zou G, Ochiai H, Huang W, et al. (2011). Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor. J Am Chem Soc, 133, 18975–91
   PubMed Web of Science ®Google Scholar